World Mar 12, 2022

WHO exploring when and how to declare end of COVID emergency

Such a declaration would be not just a meaningful symbolic step, and would add momentum to the rollback of many pandemic-era public health policies.

World May 6, 2021

Vaccines work on this India variant. Experts fret about the next.

As infections surge by more than 300,000 cases for 14 straight days, India’s limited ability to track new mutations emerging from its outbreak is a growing concern for scientists.

World / Science & Health Apr 14, 2021

Vaccine blood-clot side effect puts focus on immune reaction

Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.

World / Science & Health Dec 21, 2020

Vaccines don’t mean we’ll see the last of COVID-19, experts warn

Even with the latest technologies, money and might behind the unprecedented global drive to knock out COVID-19, the disease is unlikely to be eliminated any time soon.

Asia Pacific | FOCUS Feb 24, 2020

As pandemic looms, world's top disease fighter engages Xi in delicate quest for cooperation

Tedros Adhanom Ghebreyesus has perhaps the most thankless job in global public health. As director-general of the World Health Organization, the former Ethiopian health minister is racing against time to prevent a dangerous new coronavirus in China from precipitating a worldwide pandemic. Yet containing and ...

Business Oct 27, 2018

Trump springs globalist surprise with medicare drug-pricing plan

A drug-pricing plan unveiled by the Trump administration has put the U.S. on a path toward policies like those in Europe, where governments use tight cost controls. Under the proposal, announced at an event at the Department of Health and Human Services on Thursday, President ...

Business / Corporate Mar 29, 2018

Takeda shares slide amid $50 billion takeover bid for Shire

Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever. The decline in early Tokyo ...